Clin2
NCT07164183Possibly a fitRecruiting

Comparing two drugs for endometriosis pain relief

Endometriosis

Treatments studied

Part of Pain, Women’s health & pregnancy clinical trials.

This study tests if a new drug called Indinol Forto works as well as the standard drug Visanne for reducing endometriosis-related pelvic pain. It is for women with surgically confirmed endometriosis who have regular cycles and moderate to severe pain.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
290 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 45 years old, still having menstrual periods.
  • You have been diagnosed with endometriosis through surgery (laparoscopy or laparotomy) within the last 5 years.
  • You have regular menstrual cycles lasting 24 to 38 days without using hormone therapy.
  • You have pelvic pain from endometriosis that is at least moderate (score 3.5 or higher on a 0-10 pain scale).
  • You agree to use highly effective birth control during the study and for 2 months after.
  • You do not have other conditions causing pelvic pain, like large ovarian cysts or active infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07100782Recruiting· Phase 3
Estrogen & pain trial for endometriosis pelvic pain

This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.

Ann Arbor, Michigan
NCT07318688Recruiting· Phase 3
Testing HMI-115 for endometriosis pain

This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.

Beijing, Beijing Municipality
NCT07260669Recruiting· Phase 2
Vipoglanstat for endometriosis-related pelvic pain

This study tests an investigational drug called Vipoglanstat for women with endometriosis-related pelvic pain that happens even when they are not on their period. The goal is to see if it can reduce pain and improve quality of life.

Blagoevgrad
NCT06543550Recruiting· Phase 4
Comparing implant and pill for endometriosis

This trial compares an implant that releases the hormone gestrinone with a daily pill called dienogest to see which works better for treating endometriosis symptoms. It might be a good option if you have mild to moderate endometriosis and are looking for a non-surgical treatment.

Brasília, Federal District
NCT05059626Enrolling by invitation· Phase 4
Test simvastatin and Duavee for endometriosis symptoms

This trial studies whether simvastatin and Duavee can improve endometriosis-related symptoms linked to small blood-vessel problems. You may be eligible if you’re a woman aged 18–45 with confirmed endometriosis and meet safety requirements.

New Haven, Connecticut
NCT06952296Not yet recruiting
Dydrogesterone for endometriosis-related pain

This trial tests a hormone medicine called dydrogesterone (Duphaston) to see if it eases pain caused by endometriosis. It is for women with regular periods and a confirmed endometriosis diagnosis who are not using other hormone treatments.

Hear when a new Endometriosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.